ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0440

Representation of Women as Authors of Rheumatology Research Articles

Ekta Bagga1, Sarah Stewart2, Gregory Gamble1, Janine Hill1, Andrew Grey1 and Nicola Dalbeth1, 1University of Auckland, Auckland, New Zealand, 2The University of Auckland, Auckland, New Zealand

Meeting: ACR Convergence 2020

Keywords: gender, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Healthcare Disparities in Rheumatology (0439–0443)

Session Type: Abstract Session

Session Time: 4:00PM-4:50PM

Background/Purpose: In academic medicine, journal article authorship is central to career advancement and promotion. This study aimed to examine the contemporary representation of women as first and senior authors of rheumatology-related original research articles.

Methods: The gender of first and senior author, disease category, research design and funding source were extracted from rheumatology original research articles published in high impact rheumatology and general medical journals between 2015 and 2019.  

Results: 7,651 original research articles were included in the analysis. In total, there were 51.5% [95% CI 50.4%, 52.6%] articles with women first authors and 35.3% [95% CI 34.2%, 36.4%] with women senior authors.  Women were significantly less likely to be first and senior authors of articles reporting randomized controlled trials compared with other clinical research designs (P< 0.001), and of articles reporting industry-funded/industry-initiated studies compared with studies not funded by industry (P≤0.01).  For articles reporting industry-funded/industry-initiated randomized controlled trials, women were first authors in 18.5% [95% CI 13.8%, 24.0%] and senior authors in 23.9% [95% CI 18.6%, 29.8%].

Conclusion: In rheumatology journal articles, there is gender parity for first authorship, but women are under-represented in senior authorship positions. Under-representation of women in authorship is particularly apparent in articles reporting randomized controlled trials, especially those that are initiated by industry.


Disclosure: E. Bagga, None; S. Stewart, None; G. Gamble, None; J. Hill, None; A. Grey, None; N. Dalbeth, AstraZeneca, 1, 2, Abbvie, 1, Arthrosi, 1, Dyve BioSciences, 1, Selecta, 1, Janssen, 1.

To cite this abstract in AMA style:

Bagga E, Stewart S, Gamble G, Hill J, Grey A, Dalbeth N. Representation of Women as Authors of Rheumatology Research Articles [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/representation-of-women-as-authors-of-rheumatology-research-articles/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/representation-of-women-as-authors-of-rheumatology-research-articles/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology